BioCryst Pharma (BCRX) Posts Narrower than Expected Q4 Loss

Go back to BioCryst Pharma (BCRX) Posts Narrower than Expected Q4 Loss
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.86 +0.16 (1.65%)
Previous Close $9.70    52 Week High $10.98 
Open $9.93    52 Week Low $1.63 
Day High $10.03    P/E N/A 
Day Low $9.77    EPS $-0.68 
Volume 1,200,101